Pfizer - 51 Year Dividend History | PFE

Historical dividend payout and yield for Pfizer (PFE) since 1974. The current TTM dividend payout for Pfizer (PFE) as of August 21, 2025 is $1.72. The current dividend yield for Pfizer as of August 21, 2025 is 6.78%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $144.299B $63.627B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $667.669B 43.68
Johnson & Johnson (JNJ) United States $430.707B 17.88
AbbVie (ABBV) United States $369.476B 19.75
Novartis AG (NVS) Switzerland $268.806B 14.56
Roche Holding AG (RHHBY) Switzerland $259.301B 0.00
Novo Nordisk (NVO) Denmark $242.450B 14.68
Merck (MRK) United States $211.462B 11.08
Sanofi (SNY) France $124.077B 12.29
Bayer (BAYRY) Germany $31.870B 6.01
Innoviva (INVA) United States $1.257B 12.39